bioRxiv Science⌕ Search

bioRxiv · 10.1101/631473

Spatial Confidence Sets for Raw Effect Size Images

Abstract

The mass-univariate approach for functional magnetic resonance imagery (fMRI) analysis remains a widely used and fundamental statistical tool within neuroimaging. However, this method suffers from at least two fundamental limitations: First, with sample sizes growing to 4, 5 or even 6 digits, the entire approach is undermined by the null hypothesis fallacy, i.e. with sufficient sample size, there is high enough statistical power to reject the null hypothesis everywhere, making it difficult if not impossible to localize effects of interest. Second, with any sample size, when cluster-size inference is used a significant p-value only indicates that a cluster is larger than chance, and no notion of spatial uncertainty is provided. Therefore, no perception of confidence is available to express the size or location of a cluster that could be expected with repeated sampling from the population.\n\nIn this work, we address these issues by extending on a method proposed by Sommerfeld, Sain, and Schwartzman (2018) to develop spatial Confidence Sets (CSs) on clusters found in thresholded raw effect size maps. While hypothesis testing indicates where the null, i.e. a raw effect size of zero, can be rejected, the CSs give statements on the locations where raw effect sizes exceed, and fall short of, a non-zero threshold, providing both an upper and lower CS.\n\nWhile the method can be applied to any parameter in a mass-univariate General Linear Model, we motivate the method in the context of BOLD fMRI contrast maps for inference on percentage BOLD change raw effects. We propose several theoretical and practical implementation advancements to the original method in order to deliver an improved performance in small-sample settings. We validate the method with 3D Monte Carlo simulations that resemble fMRI data. Finally, we compute CSs for the Human Connectome Project working memory task contrast images, illustrating the brain regions that show a reliable %BOLD change for a given %BOLD threshold.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bowring, A., Telschow, F., Schwartzman, A., Nichols, T.. 2019-05-08. Spatial Confidence Sets for Raw Effect Size Images. https://doi.org/10.1101/631473

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗